Huaren Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 37.3329 million yuan, a year-on-year decrease of 49.01%

Huaren Pharmaceutical released its semi-annual report for 2025, with operating revenue of 624 million yuan, a year-on-year decrease of 19.13%; net profit attributable to the parent company of 37.3329 million yuan, a year-on-year decrease of 49.01%; net profit excluding non-recurring gains and losses of 27.6892 million yuan, a year-on-year decrease of 59.17%; basic earnings per share of 0.0316 yuan